You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CHLOROQUINE PHOSPHATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Chloroquine Phosphate patents expire, and what generic alternatives are available?

Chloroquine Phosphate is a drug marketed by Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Suven Pharms, Teva, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in CHLOROQUINE PHOSPHATE is chloroquine phosphate. There are twenty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chloroquine phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Chloroquine Phosphate

A generic version of CHLOROQUINE PHOSPHATE was approved as chloroquine phosphate by IMPAX LABS on August 29th, 2003.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CHLOROQUINE PHOSPHATE?
  • What are the global sales for CHLOROQUINE PHOSPHATE?
  • What is Average Wholesale Price for CHLOROQUINE PHOSPHATE?
Drug patent expirations by year for CHLOROQUINE PHOSPHATE
Recent Clinical Trials for CHLOROQUINE PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of ArizonaPhase 1
Translational Genomics Research InstitutePhase 1
HonorHealth Research InstitutePhase 1

See all CHLOROQUINE PHOSPHATE clinical trials

Pharmacology for CHLOROQUINE PHOSPHATE
Drug ClassAntimalarial
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROQUINE PHOSPHATE

US Patents and Regulatory Information for CHLOROQUINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 083082-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Md Pharm CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 087228-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Impax Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 040516-001 Aug 29, 2003 AA RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Teva CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 087504-001 Jan 13, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Natco Pharma Ltd CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 091621-001 Jan 21, 2011 AA RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 088030-001 Dec 21, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

CHLOROQUINE PHOSPHATE Market Analysis and Financial Projection Experimental

Chloroquine Phosphate Market Dynamics and Financial Trajectory

Market Overview

The global Chloroquine Phosphate Market is poised for steady growth, driven by several key factors. Here’s a detailed look at the market dynamics and financial trajectory of this essential antimalarial drug.

Market Size and Growth

The Chloroquine Phosphate Market is projected to grow at a Compound Annual Growth Rate (CAGR) of around 3% during the forecast period, reaching a market value of over $500 million by 2028[1][4].

Key Drivers

Several factors are driving the growth of the Chloroquine Phosphate Market:

Continuing Burden of Malaria

The high prevalence of malaria in certain regions, particularly in sub-Saharan Africa and parts of Asia, continues to drive the demand for chloroquine phosphate. This drug remains a key component of malaria control strategies in these areas[1][3].

Research and Development

Ongoing research into the potential applications of chloroquine and its derivatives beyond their traditional antimalarial uses is a significant driver. This includes exploring its use in the treatment of autoimmune disorders, viral infections, and certain types of cancer[1][4].

Pandemic Preparedness

The increasing emphasis on pandemic preparedness and response strategies has also boosted the demand for chloroquine phosphate, as it is seen as a critical component in the arsenal against infectious diseases[1].

Geographical Distribution

The market is geographically diverse, but some regions dominate due to specific factors:

Africa

Africa accounts for the largest share of the Chloroquine Phosphate Market due to the high prevalence of malaria and the continued use of chloroquine phosphate in malaria control programs. Sub-Saharan Africa bears a significant portion of global malaria cases and deaths[1].

Asia-Pacific

The Asia-Pacific region is expected to witness the fastest growth in the Chloroquine Phosphate Market. Countries like India and parts of Southeast Asia have a high prevalence of malaria, and there is ongoing research into alternative therapeutic applications of chloroquine phosphate in this region[1][3].

North America and Europe

These regions have a relatively smaller share in the market due to their success in reducing the burden of malaria and their shift towards more effective antimalarial treatments like artemisinin-based combination therapies. However, they remain involved in research and development activities related to chloroquine phosphate[1].

Segment Analysis

The market can be segmented into several key areas:

Malaria Prevention and Treatment

This segment dominates the Chloroquine Phosphate Market, as chloroquine phosphate remains a crucial component of malaria control strategies globally[1].

Hospital and Clinic Segment

Chloroquine phosphate is primarily administered and dispensed in healthcare facilities, making the hospital and clinic segment the largest in terms of distribution[1].

Competitive Landscape

The Chloroquine Phosphate Market is characterized by the presence of a few major players, including large pharmaceutical companies and specialized manufacturers of antimalarial drugs. Companies like Bayer, Guangzhou Baiyunshan Pharmaceutical Holdings Company, and others are actively engaged in the production, distribution, and supply of chloroquine phosphate[1][4].

Financial Trajectory

The financial outlook for the Chloroquine Phosphate Market is cautiously optimistic:

Revenue Growth

The market is expected to reach a valuation of over $500 million by 2028, with a CAGR of around 3% during the forecast period[1].

Regional Revenue

  • Africa will continue to dominate the market due to the high prevalence of malaria.
  • The Asia-Pacific region will experience the fastest growth due to ongoing efforts to combat malaria and explore alternative therapeutic applications[1][3].

Challenges and Opportunities

While the market faces challenges such as drug resistance and the shift towards alternative antimalarial treatments, there are significant opportunities in exploring new therapeutic applications and improving global access and distribution[1].

Future Outlook

The future of the Chloroquine Phosphate Market is shaped by several factors:

Continued Demand for Malaria Control

The ongoing burden of malaria in certain regions will continue to drive the demand for chloroquine phosphate as a component of malaria control strategies[1].

Research and Development

The potential use of chloroquine and its derivatives in managing other medical conditions will unlock new market opportunities and diversify revenue streams for market players[1].

Technological Advancements

Advancements in technology, including more advanced diagnostic tools and treatments, will increase the effectiveness and adoption of antimalarial drugs, including chloroquine phosphate[3].

Key Takeaways

  • The Chloroquine Phosphate Market is projected to grow at a CAGR of around 3% until 2028.
  • Africa dominates the market due to the high prevalence of malaria.
  • The Asia-Pacific region is expected to witness the fastest growth.
  • The market is driven by the continuing burden of malaria, ongoing research, and pandemic preparedness.
  • Major players include large pharmaceutical companies and specialized manufacturers.
  • The market faces challenges such as drug resistance but presents opportunities in new therapeutic applications.

Frequently Asked Questions

1. What is the projected growth rate of the Chloroquine Phosphate Market?

The Chloroquine Phosphate Market is projected to grow at a CAGR of around 3% during the forecast period[1].

2. Which region dominates the Chloroquine Phosphate Market?

Africa dominates the Chloroquine Phosphate Market due to the high prevalence of malaria and the continued use of chloroquine phosphate in malaria control programs[1].

3. What are the key drivers of the Chloroquine Phosphate Market?

The key drivers include the continuing burden of malaria, ongoing research into new applications of chloroquine, and the increasing emphasis on pandemic preparedness and response strategies[1].

4. Which segment dominates the Chloroquine Phosphate Market in terms of distribution?

The hospital and clinic segment dominates the market, as chloroquine phosphate is primarily administered and dispensed in healthcare facilities[1].

5. What are the potential new applications of chloroquine phosphate?

Chloroquine phosphate is being researched for its potential use in the treatment of autoimmune disorders, viral infections, and certain types of cancer[1][4].

Cited Sources:

  1. Data Horizzon Research: Chloroquine Phosphate Market Size, Share & Forecast 2033.
  2. ACS Publications: Intermolecular Recognition of the Antimalarial Drug Chloroquine.
  3. Custom Market Insights: Global Antimalarial Drugs Market Size, Trends, Share 2030.
  4. Cognitive Market Research: Global Chloroquine Phosphate Market Report 2024 Edition.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.